Completed PHASE3 INTERVENTIONAL 2-arm NCT00742599

Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy

Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy (Randomized, Double-blind, Parallel-assignment , Placebo-controlled Study)

Sponsor: Nihon Pharmaceutical Co., Ltd

Conditions Patients Undergoing Gastric Endoscopy

Interventions NPO-11 Placebo

Updated 5 times since 2017 Last updated: Nov 8, 2010 Started: Sep 30, 2008 Primary completion: Apr 30, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Patients Undergoing Gastric Endoscopy and is currently completed. Nihon Pharmaceutical Co., Ltd leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nihon Pharmaceutical Co., Ltd

Data source: Nihon Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansai, Japan
• Kanto, Japan